Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 293.00
+7.50 (2.63%)
Jan 13, 2026, 11:35 AM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 75.08 billion as of January 12, 2026. Its market cap has increased by 9.87% in one year.
Market Cap
75.08B
Enterprise Value
81.83B
Revenue
18.66B
Ranking
n/a
PE Ratio
15.83
Stock Price
293.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 75.08B, an increase of 717.21%. That is a compound annual growth rate of 20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 75.08B | 0.88% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 191.21B |
| Bora Pharmaceuticals Co., LTD. | 62.63B |
| Heron Neutron Medical | 62.52B |
| Oneness Biotech | 33.01B |
| Lumosa Therapeutics | 30.74B |
| Center Laboratories | 30.57B |
| Lin BioScience | 30.28B |